- Home
- RWAY vs CTMX Comparison
RWAY vs CTMX Comparison
Compare RWAY & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- CTMX
- Stock Information
- Founded
- RWAY 2015
- CTMX 2008
- Country
- RWAY United States
- CTMX United States
- Employees
- RWAY N/A
- CTMX N/A
- Industry
- RWAY
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- RWAY
- CTMX Health Care
- Exchange
- RWAY Nasdaq
- CTMX Nasdaq
- Market Cap
- RWAY 410.4M
- CTMX 349.6M
- IPO Year
- RWAY 2021
- CTMX 2015
- Fundamental
- Price
- RWAY $10.23
- CTMX $1.96
- Analyst Decision
- RWAY Buy
- CTMX Strong Buy
- Analyst Count
- RWAY 6
- CTMX 3
- Target Price
- RWAY $11.00
- CTMX $5.67
- AVG Volume (30 Days)
- RWAY 217.5K
- CTMX 2.4M
- Earning Date
- RWAY 11-11-2025
- CTMX 11-06-2025
- Dividend Yield
- RWAY 13.70%
- CTMX N/A
- EPS Growth
- RWAY 153.06
- CTMX 263.20
- EPS
- RWAY 1.91
- CTMX 0.49
- Revenue
- RWAY $140,975,000.00
- CTMX $141,100,000.00
- Revenue This Year
- RWAY N/A
- CTMX N/A
- Revenue Next Year
- RWAY N/A
- CTMX N/A
- P/E Ratio
- RWAY $5.34
- CTMX $3.99
- Revenue Growth
- RWAY N/A
- CTMX 18.01
- 52 Week Low
- RWAY $8.35
- CTMX $0.40
- 52 Week High
- RWAY $11.73
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- RWAY 32.39
- CTMX 42.56
- Support Level
- RWAY $10.60
- CTMX $2.04
- Resistance Level
- RWAY $10.92
- CTMX $2.16
- Average True Range (ATR)
- RWAY 0.15
- CTMX 0.13
- MACD
- RWAY -0.05
- CTMX -0.01
- Stochastic Oscillator
- RWAY 7.38
- CTMX 15.00
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.